跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,233 条关于
“Bipolar I disorder”
全部
64,233
临床试验
54,196
药物
887
机构
118
资讯
9,032
去年
FDA Approves Iloperidone (Fanapt®) for Acute Treatment of Bipolar I Disorder
去年
FDA Accepts Review of UZEDY for Bipolar I Disorder Treatment Extension
去年
Vanda Pharmaceuticals Submits NDA for Novel Antipsychotic Bysanti to Treat Bipolar I Disorder and Schizophrenia
去年
SAINT iTBS Protocol Shows Promise for Bipolar I Depression
4个月前
FDA Grants Breakthrough Device Designation to Laguna Diagnostics' Blood-Based Test for Psychiatric Disorder Differentiation
去年
FDA Accepts Teva's Applications for UZEDY in Bipolar Disorder and AJOVY for Pediatric Migraines
去年
Olanzapine and Samidorphan Combination Shows Sustained Schizophrenia Symptom Control in Long-Term Study
去年
Vanda Pharmaceuticals Reports Revenue Increase and Advances Pipeline in Q3 2024
去年
AbbVie's VRAYLAR Achieves Full Provincial Coverage in Canada with Alberta Reimbursement Approval
去年
FDA Approves First Lamotrigine Oral Suspension for Epilepsy and Bipolar Disorder Treatment
第 1 页,共 904 页
上一页
下一页